TP53 germline mutation testing in early-onset breast cancer: findings from a nationwide cohort

Overview of attention for article published in Familial Cancer, January 2019

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (68th percentile)
Above-average Attention Score compared to outputs of the same age and source (60th percentile)

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 4,026 followers.

RT @UMCUgenetica: Resultaten onderzoek AIOS klinische genetica Jette Bakhuizen online: https://t.co/wWYdPO93pT. Bij jonge borstkankerpatiën…

RT @UMCUgenetica: Resultaten onderzoek AIOS klinische genetica Jette Bakhuizen online: https://t.co/wWYdPO93pT. Bij jonge borstkankerpatiën…

RT @UMCUgenetica: Resultaten onderzoek AIOS klinische genetica Jette Bakhuizen online: https://t.co/wWYdPO93pT. Bij jonge borstkankerpatiën…

RT @UMCUgenetica: Resultaten onderzoek AIOS klinische genetica Jette Bakhuizen online: https://t.co/wWYdPO93pT. Bij jonge borstkankerpatiën…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.